22 January 2021
Early animal studies by Pirbright and Oxford yield promising results for new potential COVID-19 vaccine
Studies carried out by The Pirbright Institute and the University of Oxford have shown that Oxford’s new potential vaccine against COVID-19, named RBD-SpyVLP, produces a strong antibody response in mice and pigs, providing vital information for the further development of the vaccine. Although this…
Read more